Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)

Clinical trial NCT00368082 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00368082
Sponsor: Baylor College of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Hodgkin's Disease Relapse Lymphoma, Non-Hodgkin

Start date: 2006-04-01
Primary completion: 2013-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.